Communiqués Accuray Incorporated

Actions

ARAY

US0043971052

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 09/09/2026			Varia. 5j.	Varia. 1 janv.
0,2501 ^USD	-4,54%		-3,81%	-69,67%

19/08	Transcript : Accuray Incorporated, Q4 2026 Earnings Call, Aug 19, 2026
19/08	Accuray bascule dans le rouge au quatrième trimestre, le chiffre d'affaires recule	MT

Communiqués

19/08	Accuray: Fiscal Q4 Earnings Snapshot	AQ
19/08	Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results	PR
12/08	Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments	PR
05/08	Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026	PR
30/07	Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation	PR
29/05	Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules	PR
15/05	Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer	PR
07/05	Accuray Incorporated : ARAY Q3 FY26 Earnings Call Supplemental Deck FINAL	PU
06/05	Accuray: Fiscal Q3 Earnings Snapshot	AQ
06/05	Accuray Reports Fiscal 2026 Third Quarter Financial Results	PR
22/04	Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026	PR
06/04	Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer	PR
17/02	Accuray Incorporated : Amendment to Annual Report (Form 10-K/A)	PU
04/02	Accuray: Fiscal Q2 Earnings Snapshot	AQ
04/02	Accuray Incorporated : ARAY Q2 FY26 Earnings Supplemental Deck FINAL v2	PU
04/02	Accuray Reports Fiscal 2026 Second Quarter Financial Results	PR
21/01	Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026	PR
15/12	Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth	PR
05/11	Accuray: Fiscal Q1 Earnings Snapshot	AQ
05/11	Accuray Reports Fiscal 2026 First Quarter Financial Results	PR
31/10/25	Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules	PR
28/10/25	Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025	PR
20/10/25	Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth	PR
08/10/25	Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System	PR
30/09/25	Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care	PR